drugset / Trial / NCT05155189
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A study that aimed to assess the safety and anti-tumor activity of CCAR031 injection in unresectable HCC patients.
Timeline
- Start
- 2022-02-21
- Primary completion
- 2026-05
- Completion
- 2041-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C-CAR031 | Cell therapy | — | Intravenous |
| Subject | Durvalumab | Monoclonal antibody | — | — |
| Subject | Lenvatinib | Small molecule | — | — |
| Subject | Regorafenib | Small molecule | — | — |